INTRuST Structured Assessment For Evaluation of TBI (SAFE-TBI)
NCT ID: NCT01554891
Last Updated: 2016-03-03
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
305 participants
OBSERVATIONAL
2012-02-29
2015-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
CONcussion Treatment After Combat Trauma (CONTACT)
NCT01387490
Brain Indices of Risk for Posttraumatic Stress Disorder (PTSD) After Mild Traumatic Brain Injury (mTBI)
NCT01625962
The Use of Noninvasive Brain Stimulation in Post-traumatic Stress Disorder
NCT02542709
Evaluation of Military Service and Family Members for Post Concussive and Posttraumatic Stress Symptoms
NCT03191357
Pathophysiological Understanding and Treatment of PTSD: an rTMS Approach
NCT03840369
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cohort 1
100 OEF/OIF/OND veterans returning to Joint Base Lewis-McChord and Fort Bragg who screen positive for TBI on the Post Deployment Health Assessment (PDHA) TBI screen
No interventions assigned to this group
Cohort 2
100 OEF/OIF/OND veterans seeking care at Northern New England VA Research Consortium (NNEVARC) VA Medical Centers (VAMCs) who screen positive for TBI on VA Level 1 TBI screen
No interventions assigned to this group
Cohort 3
200 participants in WRNMMC and Fort Belvoir Community Hospital Brain Indices Study (100 with mild TBI; 100 without mild TBI).
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. Military personnel returning to Joint Base Lewis-McChord and Fort Bragg from deployment in support of OEF/OIF/OND between the ages of 18-60.
2. Screen positive on the PDHA TBI screen and referred to the Madigan Army Medical Center TBI clinic and Womack Army Medical Center.
3. Capable of giving informed consent.
Cohort 2:
1. Veterans of OEF/OIF/OND between the ages of 18-60, receiving care at any of the three VAMCs that comprise the Northern New England VA Research Consortium (White River Junction, VT; Manchester, NH; Togus, ME).
2. Screen positive on the VA Level 1 TBI screen.
3. Capable of giving informed consent.
Cohort 3:
1. Must be a patient at WRNMMC or FBCH
2. Must be Defense Enrollment Eligibility Reporting System (DEERS) eligible.
3. Must be diagnosed TBI positive or certified as TBI negative by a licensed medical practitioner using Department of Defense (DoD) criteria
4. For mTBI subjects, an initial score of 13-15 on the Glasgow Coma Scale
5. Aged 18-60
Exclusion Criteria
1. Speech/language deficit of sufficient severity to preclude answering interview questions
2. Unable or unwilling to provide informed consent and Health Insurance Portability and Accountability Act (HIPAA)authorization ("unable" includes cases in which the potential subject cannot read and understand English well enough to provide informed consent).
Cohort 2:
1. Speech/language deficit of sufficient severity to preclude answering interview questions.
2. Unable or unwilling to provide informed consent and HIPAA authorization ("unable" includes cases in which the potential subject cannot read and understand English well enough to provide informed consent).
3. Second level in-depth TBI evaluation done prior to SAFE TBI interview
Cohort 3:
1. Unable or unwilling to provide informed consent and HIPAA authorization ("unable" includes cases in which the potential subject cannot read and understand English well enough to provide informed consent).
2. Penetrating head injury.
3. Record of drug or alcohol abuse or dependence in the past six months as documented in medical chart.
4. Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders -IV (SCID) reveals current or lifetime PTSD diagnosis related to life events that occurred prior to most recent deployment.
5. Taking intravenous medications for pain; participation will be delayed until such medication has been discontinued.
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
U.S. Army Medical Research and Development Command
FED
INTRuST, Post-Traumatic Stress Disorder - Traumatic Brain Injury Clinical Consortium
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Laura A. Flashman, PhD
Role: PRINCIPAL_INVESTIGATOR
Dartmouth-Hitchcock Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Walter Reed National Military Medical Center
Washington D.C., District of Columbia, United States
Togus VA Medical Center
Augusta, Maine, United States
Manchester VA Medical Center
Manchester, New Hampshire, United States
White River Junction VA Medical Center
White River Junction, Vermont, United States
Fort Belvoir Community Hopsital (FBCH)
Fort Belvoir, Virginia, United States
Madigan Army Medical Center
Fort Lewis, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
INTRuST-SAFE-TBI
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.